Neurolieve Biosciences Overview
- Year Founded
-
2024
- Status
-
Private
- Latest Deal Type
-
Seed
- Latest Deal Amount
-
$162K
- Investors
-
2
Neurolieve Biosciences General Information
Description
Developer of a bioengineered protein-based therapy designed for peripheral neuropathic pain. The company's technology offers bioengineered protein-based drug candidates that target galanin receptors in peripheral nerve cells to reduce pain sensitivity and promote nerve repair without affecting the central nervous system, enabling pharmaceutical companies and patients with peripheral neuropathy to access potential treatments that address both pain symptoms and underlying nerve damage.
Contact Information
Website
www.neurolievebiosciences.comCorporate Office
- Lifearc 7th Floor, Lynton House
- 7-12 Tavistock Square
- London WC1H 9LT
- England, United Kingdom
Corporate Office
- Lifearc 7th Floor, Lynton House
- 7-12 Tavistock Square
- London WC1H 9LT
- England, United Kingdom
Neurolieve Biosciences Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 2. Seed Round | 27-May-2024 | $162K | Completed | Pre-Clinical Trials | ||
| 1. University Spin-Out | 01-Jan-2024 | Completed | Pre-Clinical Trials |
Neurolieve Biosciences Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Neurolieve Biosciences Investors (2)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| NLC Health Ventures | Venture Capital | Minority | ||
| University of Bristol | University |
Neurolieve Biosciences FAQs
-
When was Neurolieve Biosciences founded?
Neurolieve Biosciences was founded in 2024.
-
Where is Neurolieve Biosciences headquartered?
Neurolieve Biosciences is headquartered in London, United Kingdom.
-
What industry is Neurolieve Biosciences in?
Neurolieve Biosciences’s primary industry is Drug Discovery.
-
Is Neurolieve Biosciences a private or public company?
Neurolieve Biosciences is a Private company.
-
What is Neurolieve Biosciences’s current revenue?
The current revenue for Neurolieve Biosciences is .
-
How much funding has Neurolieve Biosciences raised over time?
Neurolieve Biosciences has raised $162K.
-
Who are Neurolieve Biosciences’s investors?
NLC Health Ventures and University of Bristol have invested in Neurolieve Biosciences.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
